These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 18379042)
1. Lactoferrin inhibits platelet production from human megakaryocytes in vitro. Matsumura-Takeda K; Ishida T; Sogo S; Isakari Y; Taki T; Sudo T; Kiwada H Biol Pharm Bull; 2008 Apr; 31(4):569-73. PubMed ID: 18379042 [TBL] [Abstract][Full Text] [Related]
2. CD41+/CD45+ cells without acetylcholinesterase activity are immature and a major megakaryocytic population in murine bone marrow. Matsumura-Takeda K; Sogo S; Isakari Y; Harada Y; Nishioka K; Kawakami T; Ono T; Taki T Stem Cells; 2007 Apr; 25(4):862-70. PubMed ID: 17420226 [TBL] [Abstract][Full Text] [Related]
3. CD34+ cells derived from fetal liver contained a high proportion of immature megakaryocytic progenitor cells. Ma DC; Sun YH; Zuo W; Chang KZ; Chu JJ; Liu YG Eur J Haematol; 2000 May; 64(5):304-14. PubMed ID: 10863976 [TBL] [Abstract][Full Text] [Related]
4. Three-stage ex vivo expansion of high-ploidy megakaryocytic cells: toward large-scale platelet production. Panuganti S; Schlinker AC; Lindholm PF; Papoutsakis ET; Miller WM Tissue Eng Part A; 2013 Apr; 19(7-8):998-1014. PubMed ID: 23190353 [TBL] [Abstract][Full Text] [Related]
5. Effects of cytokines on platelet production from blood and marrow CD34+ cells. Norol F; Vitrat N; Cramer E; Guichard J; Burstein SA; Vainchenker W; Debili N Blood; 1998 Feb; 91(3):830-43. PubMed ID: 9446643 [TBL] [Abstract][Full Text] [Related]
6. Preferential ex vivo expansion of megakaryocytes from human cord blood CD34+-enriched cells in the presence of thrombopoietin and limiting amounts of stem cell factor and Flt-3 ligand. Proulx C; Boyer L; Hurnanen DR; Lemieux R J Hematother Stem Cell Res; 2003 Apr; 12(2):179-88. PubMed ID: 12804177 [TBL] [Abstract][Full Text] [Related]
7. GSK-3β negatively regulates megakaryocyte differentiation and platelet production from primary human bone marrow cells in vitro. Ono M; Matsubara Y; Shibano T; Ikeda Y; Murata M Platelets; 2011; 22(3):196-203. PubMed ID: 21231855 [TBL] [Abstract][Full Text] [Related]
8. Ultrastructure of platelet formation by human megakaryocytes cultured with the Mpl ligand. Cramer EM; Norol F; Guichard J; Breton-Gorius J; Vainchenker W; Massé JM; Debili N Blood; 1997 Apr; 89(7):2336-46. PubMed ID: 9116277 [TBL] [Abstract][Full Text] [Related]
9. Critical role for ERK1/2 in bone marrow and fetal liver-derived primary megakaryocyte differentiation, motility, and proplatelet formation. Mazharian A; Watson SP; Séverin S Exp Hematol; 2009 Oct; 37(10):1238-1249.e5. PubMed ID: 19619605 [TBL] [Abstract][Full Text] [Related]
10. Study of gene expression profile during cord blood-associated megakaryopoiesis. Lim CK; Hwang WY; Aw SE; Sun L Eur J Haematol; 2008 Sep; 81(3):196-208. PubMed ID: 18510698 [TBL] [Abstract][Full Text] [Related]
11. Genetically engineered blood pharming: generation of HLA-universal platelets derived from CD34+ progenitor cells. Figueiredo C; Blaszczyk R J Stem Cells; 2014; 9(3):149-61. PubMed ID: 25157449 [TBL] [Abstract][Full Text] [Related]
12. [Changes in cyclin expression during proliferation and differentiation of CD34(+) cells derived from fetal liver induced by thrombopoietin]. Ma DC; Jin BQ; Sun YH; Chang KZ; Dai B; Chu JJ; Liu YG Sheng Li Xue Bao; 2001 Aug; 53(4):296-302. PubMed ID: 11930209 [TBL] [Abstract][Full Text] [Related]
13. Ex vivo expansion of megakaryocyte progenitor cells: cord blood versus mobilized peripheral blood. De Bruyn C; Delforge A; Martiat P; Bron D Stem Cells Dev; 2005 Aug; 14(4):415-24. PubMed ID: 16137231 [TBL] [Abstract][Full Text] [Related]
14. Humanized VB22B minibody for human Mpl stimulates human megakaryopoiesis but does not enhance platelet aggregation. Matsuki E; Miyakawa Y; Yamane A; Okamoto S Exp Hematol; 2011 Aug; 39(8):829-36. PubMed ID: 21605620 [TBL] [Abstract][Full Text] [Related]
15. Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production. Horie K; Miyazaki H; Hagiwara T; Tahara E; Matsumoto A; Kadoya T; Ogami K; Kato T Exp Hematol; 1997 Feb; 25(2):169-76. PubMed ID: 9015217 [TBL] [Abstract][Full Text] [Related]
16. Anagrelide metabolite induces thrombocytopenia in mice by inhibiting megakaryocyte maturation without inducing platelet aggregation. Lane WJ; Hattori K; Dias S; Peerschke EI; Moore MA; Blanset DL; Lang PC; Petrone M; Rafii S Exp Hematol; 2001 Dec; 29(12):1417-24. PubMed ID: 11750100 [TBL] [Abstract][Full Text] [Related]
17. Comparative analyses of megakaryocytes derived from cord blood and bone marrow. Miyazaki R; Ogata H; Iguchi T; Sogo S; Kushida T; Ito T; Inaba M; Ikehara S; Kobayashi Y Br J Haematol; 2000 Mar; 108(3):602-9. PubMed ID: 10759720 [TBL] [Abstract][Full Text] [Related]
18. Effects of c-mpl ligand on cytoplasmic maturation of murine megakaryocytes and on platelet production. Ishida Y; Ito T; Kuriya Si J Histochem Cytochem; 1998 Jan; 46(1):49-57. PubMed ID: 9405494 [TBL] [Abstract][Full Text] [Related]
19. Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro. Iraqi M; Perdomo J; Yan F; Choi PY; Chong BH Haematologica; 2015 May; 100(5):623-32. PubMed ID: 25682608 [TBL] [Abstract][Full Text] [Related]
20. NF-E2-mediated enhancement of megakaryocytic differentiation and platelet production in vitro and in vivo. Fock EL; Yan F; Pan S; Chong BH Exp Hematol; 2008 Jan; 36(1):78-92. PubMed ID: 17923245 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]